Since the identification of proper markers that precisely predict aggressiveness of gastric cancer could improve the survival of these patients by managing their treatments, we asked if combined evaluation of AR and AURKA expression could introduce a proper prognostic marker. The gene discussed is AURKA; the disease is gastric cancer.